Orthofix Announces FDA Clearance and Initial Patient Implant of the Company’s First 3D-Printed Titanium Cervical Spacer System with Nanovate Technology

Go back to Orthofix Announces FDA Clearance and Initial Patient Implant of the Company’s First 3D-Printed Titanium Cervical Spacer System with Nanovate Technology
Orthofix International NV (NASDAQ: OFIX) Delayed: 9.72 --0 (-0%)
Previous Close $9.72    52 Week High $48.25 
Open $9.72    52 Week Low $35.61 
Day High $9.72    P/E 4.07 
Day Low $9.72    EPS $2.39 
Volume 2